Summary Panel Discussion: Breaking Down the Cutting Edge of Bispecific ADCs & Novel Target Validation to De-Risk Novel ADC Therapeutic Development
3:00 pm - Wednesday 14th October 2026
Round up the conversation from the Discovery Biology presentations in a closing panel discussion with the speakers. Make sure to come with your questions prepared as the presenters explore the risk and rationale for pursuing novel ADC targets, and the potential of bispecific ADCs to enhance tumor targeting and therapeutic index compared to traditional ADCs.
